Latest Innovation News

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.

ECS Botanics reports a 20% quarterly surge in direct-to-consumer sales and a record medicinal cannabis harvest, supported by an expanded loan facility to fuel further growth.

Winsome Resources progresses key permitting and exploration milestones at its Adina Lithium Project while maintaining a strong cash position and deferring the Renard Option decision amid subdued lithium market conditions.

Iron Road Ltd has secured its key mining lease through 2026 and entered a strategic farm-in agreement targeting heavy mineral sands, navigating a tough iron ore investment climate and evolving green energy partnerships.

Wide Open Agriculture reports a remarkable 243% jump in cash receipts driven by soaring lupin protein sales and secures a strategic foothold in China through an exclusive distribution deal.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has advanced to the next phase of securing a substantial US$900 million funding package from Brazilian government agencies to develop rare earth refining and recycling facilities.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.

DXN Limited reported a robust Q4 FY25 with 51% revenue growth, securing key contracts and completing a strategic property acquisition that strengthens its modular data centre footprint.

OD6 Metals has reported strong high-grade copper results from its maiden drilling at Gulf Creek, NSW, alongside progress in rare earth metallurgical testing and closure of a regulatory investigation.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

WiseTech Global has appointed Zubin Appoo as its permanent CEO, succeeding interim leader Andrew Cartledge who will retire later this year. Appoo’s deep company roots and broad tech leadership experience position him to steer WiseTech’s next chapter.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.